Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Read

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Antiviral Therapy|August 24, 2012
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapyLu Zheng, Ronald J Bosch, Ellen S Chan, et al.
Retina (Philadelphia, Pa.)|December 23, 2016
DIDANOSINE RETINAL TOXICITYSara J Haug, Robert W Wong, Shelley Day, et al.
JAMA Ophthalmology|March 29, 2014
Impact of an electronic health record operating room management system in ophthalmology on documentation time, surgical volume, and staffingDavid S Sanders, Sarah Read-Brown, Daniel C Tu, et al.
Ophthalmology|May 21, 2013
Electronic health record systems in ophthalmology: impact on clinical documentationDavid S Sanders, Daniel J Lattin, Sarah Read-Brown, et al.
JAMA Ophthalmology|October 20, 2017
Time Requirements for Electronic Health Record Use in an Academic Ophthalmology CenterSarah Read-Brown, Michelle R Hribar, Leah G Reznick, et al.
Transactions of the American Ophthalmological Society|October 30, 2013
Evaluation of electronic health record implementation in ophthalmology at an academic medical center (an American Ophthalmological Society thesis)Michael F Chiang, Sarah Read-Brown, Daniel C Tu, et al.
Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral TherapyConstance A Benson, Janet W Andersen, Bernard J C Macatangay, et al.
AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antiviral Therapy|August 24, 2012
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapyLu Zheng, Ronald J Bosch, Ellen S Chan, et al.
Retina (Philadelphia, Pa.)|December 23, 2016
DIDANOSINE RETINAL TOXICITYSara J Haug, Robert W Wong, Shelley Day, et al.
JAMA Ophthalmology|March 29, 2014
Impact of an electronic health record operating room management system in ophthalmology on documentation time, surgical volume, and staffingDavid S Sanders, Sarah Read-Brown, Daniel C Tu, et al.
Ophthalmology|May 21, 2013
Electronic health record systems in ophthalmology: impact on clinical documentationDavid S Sanders, Daniel J Lattin, Sarah Read-Brown, et al.
JAMA Ophthalmology|October 20, 2017
Time Requirements for Electronic Health Record Use in an Academic Ophthalmology CenterSarah Read-Brown, Michelle R Hribar, Leah G Reznick, et al.
Transactions of the American Ophthalmological Society|October 30, 2013
Evaluation of electronic health record implementation in ophthalmology at an academic medical center (an American Ophthalmological Society thesis)Michael F Chiang, Sarah Read-Brown, Daniel C Tu, et al.
Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral TherapyConstance A Benson, Janet W Andersen, Bernard J C Macatangay, et al.
AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Pageof 3